Probiotics are in action this week, effectively tackling the common cold, allergy and triglycerides, according to a recent edition of OTC.Newsflash, published by Nicholas Hall & Company:
Allergy attacked! A Vanderbilt University (US) review of 23 studies found that probiotics were linked to improvement in at least one facet of a patient’s health – either rhinitis-specific quality of life or symptoms — in 17 of the studies. (International Forum of Allergy & Rhinology, April 20,2015).
Triglycerides tackled! Researchers at The Yonsei University (South Korea) found that dual probiotic strains Lactobacillus curvatus HY7601 + Lactobacillus plantarum KY1032 demonstrated triglyceride-lowering effects vs placebo in a 12-week study of 92 participants with hypertriglyceridaemia but without diabetes. (Nutrition, Metabolism & Cardiovascular Diseases, May 13, 2015)
Sick days shortened! The American Journal of Clinical Nutrition reports that in cases of influenza-like illness, the number of sick days was reduced to five for a group that consumed a daily beverage with 1bn live bacteria (Chr Hansen’s L.casei 431 probiotic strain) vs eight days in a placebo group. The proportion of subjects who required healthcare system support during the follow-up period fell from 28% to 22% with probiotic consumption.
Global sales of probiotic dietary supplements have increased by $1bn to $2.7bn in the past five years, according to Nicholas Hall & Company’s global OTC sales database, DB6.